Zaidan, Nadim https://orcid.org/0000-0003-0988-9494
Jalloul, Youssef
Goldfarb, David S.
Azar, Hiba
El-Sayegh, Suzanne
Article History
Received: 19 August 2024
Accepted: 5 November 2024
First Online: 1 December 2024
Declarations
:
: Disclosures—Goldfarb: Consultant: Arbor Biotechnologies, Alnylam, Lilac Pharmaceuticals; Research: Novo Nordisk, Travere; Owner: Moonstone Nutrition Inc. All other authors have no disclosures.
: Because of the deidentified nature of the NIS database, this study was considered exempt from requiring an IRB review by the Northwell Health Institutional Review Board (HSRD23-0275-NH).
: This study was done in accordance with the Declaration of Helsinki. It does not involve any animal experiment.
: Not applicable.